DONGGUK UNIVERSITY INDUSTRY-ACADEMY COOPERATION FOUNDATION
发明人:
Chang-Hoon Lee
申请号：
US15757696
公开号：
US10519512B2
申请日:
2016.08.19
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to the serine threonine kinase 32C (STK32C) gene relevant to breast cancer and a use thereof, and particularly, to a composition for the diagnosis, prevention, or treatment of breast cancer using the STK32C gene. In the present invention, changes in breast cancer cells according to STK32C gene expression differences were identified, and a breast cancer inhibitory effect according to the inhibition of expression of the STK32C gene and YB-1, which is a substrate protein, were newly verified, and thus target therapies are expected in treatment of breast cancer through more fundamental approaches.
